Telbivudine globe trial at year two: Efficacy, safety, and predictors of outcome in patients with chronic hepatitis B

被引：0
|
作者：
Han, Steven-Huy
Lai, Ching Lung
Gane, Edward J.
Liaw, Yun-Fan
Thongsawar, Satawat
Wang, Yuming
Chen, Yagang
Heathcote, E. Jenny
Rasenack, Jens
Bzowej, Natalie
Naoumov, Nikolai V.
Brown, Nathaniel A.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A765 / A765
页数：1
相关论文
共 50 条
  • [1] Telbivudine for chronic hepatitis B: the GLOBE trial
    Yuen, Man-Fung
    Lai, Ching-Lung
    FUTURE VIROLOGY, 2008, 3 (04) : 317 - 323
  • [2] 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
    Liaw, Yun-Fan
    Gane, Edward
    Leung, Nancy
    Zeuzem, Stefan
    Wang, Yuming
    Lai, Ching Lung
    Heathcote, E. Jenny
    Manns, Michael
    Bzowej, Natalie
    Niu, Junqi
    Han, Steven-Huy
    Hwang, Seong Gyu
    Cakaloglu, Yilmaz
    Tong, Myron J.
    Papatheodoridis, George
    Chen, Yagang
    Brown, Nathaniel A.
    Albanis, Efsevia
    Galil, Karin
    Naoumov, Nikolai V.
    GASTROENTEROLOGY, 2009, 136 (02) : 486 - 495
  • [3] EFFICACY AND SAFETY OF TELBIVUDINE IN PREGNANT CHRONIC HEPATITIS B PATIENTS
    Zhou Yuejin
    Zheng Jinli
    Pan Huajiang
    Jiang Shan
    HEPATOLOGY, 2011, 54 : 1015A - 1016A
  • [4] Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
    Gane, Edward J.
    Wang, Yuming
    Liaw, Yun-Fan
    Hou, JinLin
    Thongsawat, Satawat
    Wan, MoBin
    Moon, Young M.
    Jia, JiDong
    Chao, You C.
    Niu, Junqi
    Leung, Nancy
    Samuel, Didier
    Hsu, Chao Wei
    Bao, Weibin
    Lopez, Patricia
    Avila, Claudio
    LIVER INTERNATIONAL, 2011, 31 (05) : 676 - 684
  • [5] Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
    Wang, Y.
    Thongsawat, S.
    Gane, E. J.
    Liaw, Y. -F.
    Jia, J.
    Hou, J.
    Chan, H. L. Y.
    Papatheodoridis, G.
    Wan, M.
    Niu, J.
    Bao, W.
    Trylesinski, A.
    Naoumov, N. V.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e37 - e46
  • [6] Phase III comparison of telbivudine vs lamivudine in patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
    Bzowej, N.
    Lai, Cl
    Gane, E.
    Liaw, Yf
    Thongsawat, S.
    Wang, Y.
    Chen, Y.
    Heathcote, J.
    Rasenack, J.
    Naoumov, N.
    Chao, G.
    Fielman, B.
    Brown, N.
    GASTROENTEROLOGY, 2006, 130 (04) : A765 - A766
  • [7] Efficacy, safety, and predictors of response at 1 year from a phase III comparison of telbivudine versus lamivudine in patients with chronic hepatitis B
    Lim, Seng-Gee
    Lai, Ching-Lung
    Gane, Edward
    Liaw, Yun-Fan
    Thongsawat, Satawat
    Wang, Yuming
    Chen, Yagang
    Heathcote, Elizabeth J.
    Rasenack, Jens
    Naoumov, Nikolai
    Chao, George
    Fielman, Barbara
    Brown, Nathaniel A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A458 - A459
  • [8] Two-year results from the globe trial in patients with hepatitis B: Greater clinical and antiviral efficacy for telbivudine (LDT) vs. lamivudine
    Lai, Ching-Lung
    Gane, Edward
    Hsu, Chao-Wei
    Thongsawat, Satawat
    Wang, Yumin
    Chen, Yagang
    Heathcote, Elizabeth J.
    Rasenack, Jens
    Bzowej, Natalie
    Naoumov, Nikolai
    Zeuzem, Stefan
    Di Bisceglie, Adrian
    Chao, George C.
    Constance, Barbara A. Fielman
    Brown, Nathaniel A.
    HEPATOLOGY, 2006, 44 (04) : 222A - 222A
  • [9] Telbivudine globe trial: Maximal early HBV suppression is predictive of optimal two-year efficacy in nucleoside-treated hepatitis B patients
    DiBisceglie, Adrian
    Lai, Ching-Lung
    Gane, Edward
    Chen, Yi-Cheng
    Thongsawat, Satawat
    Wang, Yumin
    Chen, Yagang
    Heathcote, Elizabeth J.
    Zeuzem, Stefan
    Rasenack, Jens
    Bzowej, Natalie
    Han, Steven-Huy
    Naoumov, Nikolai
    Hwang, Seong Gyu
    Lim, Seng-Gee
    Chao, George C.
    Fielman, Barbara A.
    Brown, Nathaniel A.
    HEPATOLOGY, 2006, 44 (04) : 230A - 231A
  • [10] Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year
    Gane, E.
    Lai, C. L.
    Liaw, Y. F.
    Thongsawat, S.
    Wang, Y.
    Chen, Y.
    Heathcote, J.
    Rasenack, J.
    Bzowej, N.
    Naoumov, N.
    Chao, G.
    Fielman, B.
    Brown, N.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S183 - S184
12345